279 related articles for article (PubMed ID: 19073177)
1. Protein related to DAN and cerberus (PRDC) inhibits osteoblastic differentiation and its suppression promotes osteogenesis in vitro.
Ideno H; Takanabe R; Shimada A; Imaizumi K; Araki R; Abe M; Nifuji A
Exp Cell Res; 2009 Feb; 315(3):474-84. PubMed ID: 19073177
[TBL] [Abstract][Full Text] [Related]
2. RNA interference of the BMPR-IB gene blocks BMP-2-induced osteogenic gene expression in human bone cells.
Singhatanadgit W; Salih V; Olsen I
Cell Biol Int; 2008 Nov; 32(11):1362-70. PubMed ID: 18773965
[TBL] [Abstract][Full Text] [Related]
3. Osteoactivin acts as downstream mediator of BMP-2 effects on osteoblast function.
Abdelmagid SM; Barbe MF; Arango-Hisijara I; Owen TA; Popoff SN; Safadi FF
J Cell Physiol; 2007 Jan; 210(1):26-37. PubMed ID: 17034042
[TBL] [Abstract][Full Text] [Related]
4. Heparin inhibits BMP-2 osteogenic bioactivity by binding to both BMP-2 and BMP receptor.
Kanzaki S; Takahashi T; Kanno T; Ariyoshi W; Shinmyouzu K; Tujisawa T; Nishihara T
J Cell Physiol; 2008 Sep; 216(3):844-50. PubMed ID: 18449905
[TBL] [Abstract][Full Text] [Related]
5. Simvastatin antagonizes tumor necrosis factor-alpha inhibition of bone morphogenetic proteins-2-induced osteoblast differentiation by regulating Smad signaling and Ras/Rho-mitogen-activated protein kinase pathway.
Yamashita M; Otsuka F; Mukai T; Otani H; Inagaki K; Miyoshi T; Goto J; Yamamura M; Makino H
J Endocrinol; 2008 Mar; 196(3):601-13. PubMed ID: 18310456
[TBL] [Abstract][Full Text] [Related]
6. Cystatin C stimulates the differentiation of mouse osteoblastic cells and bone formation.
Danjo A; Yamaza T; Kido MA; Shimohira D; Tsukuba T; Kagiya T; Yamashita Y; Nishijima K; Masuko S; Goto M; Tanaka T
Biochem Biophys Res Commun; 2007 Aug; 360(1):199-204. PubMed ID: 17592728
[TBL] [Abstract][Full Text] [Related]
7. Clonal osteoblastic cell lines from p53 null mouse calvariae are immortalized and dependent on bone morphogenetic protein 2 for mature osteoblastic phenotype.
Ghosh-Choudhury N; Harris MA; Wozney J; Mundy GR; Harris SE
Biochem Biophys Res Commun; 1997 Feb; 231(1):196-202. PubMed ID: 9070248
[TBL] [Abstract][Full Text] [Related]
8. The nucleocytoplasmic shuttling protein CIZ reduces adult bone mass by inhibiting bone morphogenetic protein-induced bone formation.
Morinobu M; Nakamoto T; Hino K; Tsuji K; Shen ZJ; Nakashima K; Nifuji A; Yamamoto H; Hirai H; Noda M
J Exp Med; 2005 Mar; 201(6):961-70. PubMed ID: 15781586
[TBL] [Abstract][Full Text] [Related]
9. Twisted gastrulation and chordin inhibit differentiation and mineralization in MC3T3-E1 osteoblast-like cells.
Petryk A; Shimmi O; Jia X; Carlson AE; Tervonen L; Jarcho MP; O'connor MB; Gopalakrishnan R
Bone; 2005 Apr; 36(4):617-26. PubMed ID: 15780974
[TBL] [Abstract][Full Text] [Related]
10. Enhancement of bone morphogenetic protein-2 expression and bone formation by coumarin derivatives via p38 and ERK-dependent pathway in osteoblasts.
Tang CH; Yang RS; Chien MY; Chen CC; Fu WM
Eur J Pharmacol; 2008 Jan; 579(1-3):40-9. PubMed ID: 17980360
[TBL] [Abstract][Full Text] [Related]
11. Spaciotemporal association and bone morphogenetic protein regulation of sclerostin and osterix expression during embryonic osteogenesis.
Ohyama Y; Nifuji A; Maeda Y; Amagasa T; Noda M
Endocrinology; 2004 Oct; 145(10):4685-92. PubMed ID: 15217980
[TBL] [Abstract][Full Text] [Related]
12. Dkk2 has a role in terminal osteoblast differentiation and mineralized matrix formation.
Li X; Liu P; Liu W; Maye P; Zhang J; Zhang Y; Hurley M; Guo C; Boskey A; Sun L; Harris SE; Rowe DW; Ke HZ; Wu D
Nat Genet; 2005 Sep; 37(9):945-52. PubMed ID: 16056226
[TBL] [Abstract][Full Text] [Related]
13. Periostin-like-factor in osteogenesis.
Zhu S; Barbe MF; Liu C; Hadjiargyrou M; Popoff SN; Rani S; Safadi FF; Litvin J
J Cell Physiol; 2009 Mar; 218(3):584-92. PubMed ID: 19006175
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E2 EP4 agonist (ONO-4819) accelerates BMP-induced osteoblastic differentiation.
Nakagawa K; Imai Y; Ohta Y; Takaoka K
Bone; 2007 Oct; 41(4):543-8. PubMed ID: 17681894
[TBL] [Abstract][Full Text] [Related]
15. BMP stimulation of alkaline phosphatase activity in pluripotent mouse C2C12 cells is inhibited by dermatopontin, one of the most abundant low molecular weight proteins in demineralized bone matrix.
Behnam K; Murray SS; Brochmann EJ
Connect Tissue Res; 2006; 47(5):271-7. PubMed ID: 17118749
[TBL] [Abstract][Full Text] [Related]
16. Endogenous bone morphogenetic proteins in human bone marrow-derived multipotent mesenchymal stromal cells.
Seib FP; Franke M; Jing D; Werner C; Bornhäuser M
Eur J Cell Biol; 2009 May; 88(5):257-71. PubMed ID: 19303661
[TBL] [Abstract][Full Text] [Related]
17. The effect of recombinant human bone morphogenetic protein-4 on the osteoblastic differentiation of mouse calvarial cells affected by Porphyromonas gingivalis.
Kim CS; Choi SH; Choi BK; Chai JK; Park JB; Kim CK; Cho KS
J Periodontol; 2002 Oct; 73(10):1126-32. PubMed ID: 12416769
[TBL] [Abstract][Full Text] [Related]
18. In vitro proliferation and osteoblastic phenotype expression of cells derived from human vertebral lamina and iliac crest.
Defino HL; da Silva Herrero CF; Crippa GE; Bellesini LS; Beloti MM; Rosa AL
Spine (Phila Pa 1976); 2009 Jul; 34(15):1549-53. PubMed ID: 19564764
[TBL] [Abstract][Full Text] [Related]
19. In vitro osteoblast differentiation is negatively regulated by Hoxc8.
Zheng YJ; Chung HJ; Min H; Kang M; Kim SH; Gadi J; Kim MH
Appl Biochem Biotechnol; 2010 Mar; 160(3):891-900. PubMed ID: 19214787
[TBL] [Abstract][Full Text] [Related]
20. Sclerostin promotes the apoptosis of human osteoblastic cells: a novel regulation of bone formation.
Sutherland MK; Geoghegan JC; Yu C; Turcott E; Skonier JE; Winkler DG; Latham JA
Bone; 2004 Oct; 35(4):828-35. PubMed ID: 15454089
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
